Induced pluripotent stem cells do not fully replace embryonic stem cells
as disease models, EU- funded study shows.

A study from the Hebrew University
of Jerusalem and the Children’s Hospital in Boston has shed a new light on the properties
of induced pluripotent stem cells (iPS cells), reporting evidence that they may
not be able to replace embryonic stem cells in some research and medical
applications. The results of the study will be
presented  in Lisbon at the   International Symposium “Stem Cells...